Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hepa/Biliary Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent webcasts/CME - Hepa/Biliary Other
  • Active Ulcerative Colitis: Selection of First-Line Therapies for Better Patient Outcomes
  • Alpha1-Antitrypsin Augmentation: Approaches and Benefits
    Drug-Induced Liver Disease, Part 2
    The Meso-Rex Bypass for Portal Hypertension in Children

    Webcasts/CME archive

     Recent news - Hepa/Biliary Other
      Adding Cetuximab to Chemotherapy Increases Tumour Shrinkage In Advanced Colorectal Cancer - (DGNews)
      New Drug Regimen Shows Promising Results for Advanced Biliary-Tract Cancers - (DGNews)
      Statin use and risk of gallstone disease followed by cholecystectomy - (JAMA)
      What Is the Optimal Timing of Hepatitis C Antiviral Therapy Before and After Liver Transplantation? Presented at AASLD - (DGDispatch)
      Alcohol Does Not Appear to Increase Acetaminophen-Related Acute Liver Failure: Presented at AASLD - (DGDispatch)

      News archive

       Recent cases - Hepa/Biliary Other
        Abscess of the Round Ligament of the Liver Associated with Acute Obstructive Cholangitis and Septic Thrombosis
        An Atypical Case of Hepatic Cavernous Hemangioma: A Case Report
        Cholecystopleural Fistula in a 71-Year-Old Man with Symptoms of Pneumonia and Pleural Effusion
        Hypercalcemia in a Patient with Cholangiocarcinoma: A Case Report
        There May be a Link Between Intrahepatic Cholestasis of Pregnancy and Familial Combined Hyperlipidaemia: A Case Report

        Cases archive
          




        personal edition > hepa/biliary other > webcasts/CME
        divider
        Webcasts/CME


          E-Mail this webcast/CME to a colleague




        news Drug-Induced Liver Disease, Part 1

        Presented by:The University of Alabama School of Medicine
        LecturerDonald H. Marks, MD, PhD
        Approximate duration:1 hr.
        Summary points:This interactive, text-based CME activity outlines the effects of medications on the liver, and lists factors that can affect susceptibility to drug-induced liver disease.
        Accreditation:The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit. Expiration Date: May 28, 2012.
        Other:Text-only CME.


        Additional Information

        Audio:No
        Video:No
        Text:Yes
        Pictures/Slides:No
        Discussion group:No
        Feedback possible:No
        Minimum connection needed:28.8
        Plugins needed:No
        Registration:No


        Go to webcast/CME

        E-Mail this webcast/CME to a colleague

        Remind me of this



        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.